Flora Growth (FLGC) has released an update.
Flora Growth Corp. has entered a strategic partnership with Blossom Genetics to supply Colombian medical cannabis strains to the German market, capitalizing on the recent legalization and the surge in demand for high-quality medical cannabis. This move, starting deliveries in Q4 2024, enhances Flora’s European presence and responds to the increased patient need for new medical cannabis options in Germany.
For further insights into FLGC stock, check out TipRanks’ Stock Analysis page.
